Aligos Therapeutics, Inc.
ALGS
$7.22
-$0.43-5.62%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -29.46% | -21.45% | -19.40% | -10.82% | 142.12% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -5.94% | 15.65% | -13.20% | -6.46% | 2.73% |
| Total Current Assets | -28.04% | -19.89% | -19.16% | -10.66% | 130.45% |
|
|
|||||
| Total Current Assets | -28.04% | -19.89% | -19.16% | -10.66% | 130.45% |
| Net Property, Plant & Equipment | -15.86% | -11.75% | -8.27% | -10.78% | -6.33% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.15% | 0.28% | 11.41% | 1.27% | 0.80% |
| Total Assets | -27.08% | -19.34% | -18.52% | -10.61% | 115.00% |
|
|
|||||
| Total Accounts Payable | 91.84% | -14.38% | 18.14% | -11.73% | 73.47% |
| Total Accrued Expenses | -11.36% | -0.58% | 11.43% | 10.98% | -29.29% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.83% | 4.55% | 0.65% | 1.52% | 0.84% |
| Total Finance Division Other Current Liabilities | -- | -- | -70.98% | -- | -- |
| Total Other Current Liabilities | -- | -- | -70.98% | -- | -- |
| Total Current Liabilities | 9.84% | -3.43% | 8.50% | 6.95% | -12.83% |
|
|
|||||
| Total Current Liabilities | 9.84% | -3.43% | 8.50% | 6.95% | -12.83% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -56.79% | -39.05% | -25.04% | -23.91% | -10.78% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -28.14% | -9.02% | 45.52% | -15.40% | -84.92% |
| Total Liabilities | -6.34% | -7.76% | 15.50% | -4.13% | -65.42% |
|
|
|||||
| Common Stock & APIC | 0.19% | 0.23% | 0.21% | 0.19% | 17.39% |
| Retained Earnings | -3.59% | -3.19% | -5.34% | -2.76% | 6.97% |
| Treasury Stock & Other | -6.41% | 2.86% | 8.33% | -6.04% | -0.89% |
| Total Common Equity | -40.63% | -25.46% | -29.48% | -12.52% | 501.91% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -40.63% | -25.46% | -29.48% | -12.52% | 501.91% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -40.63% | -25.46% | -29.48% | -12.52% | 501.91% |
|
|
|||||